Mathew Blackman

Stock Analyst at TD Cowen

(4.17)
# 1,547
Out of 5,051 analysts
276
Total ratings
48.3%
Success rate
9.2%
Average return

Stocks Rated by Mathew Blackman

Stryker
Sep 22, 2026
Rated: Hold
Price Target: $355 → $298
Current: $282.60
Upside: +5.45%
Beta Bionics
Sep 14, 2026
Reiterated: Hold
Price Target: $16 → $18
Current: $17.86
Upside: +0.78%
Globus Medical
Aug 6, 2026
Reiterated: Buy
Price Target: $115
Current: $76.24
Upside: +50.84%
Insulet
Aug 6, 2026
Rated: Hold
Price Target: $294 → $144
Current: $139.81
Upside: +3.00%
Tandem Diabetes Care
Aug 6, 2026
Reiterated: Buy
Price Target: $28
Current: $16.45
Upside: +70.21%
Alphatec Holdings
Aug 5, 2026
Rated: Buy
Price Target: $11 → $13
Current: $11.25
Upside: +15.56%
Orthofix Medical
Aug 5, 2026
Reiterated: Hold
Price Target: $12
Current: $9.28
Upside: +29.31%
Zimmer Biomet Holdings
Aug 5, 2026
Reiterated: Buy
Price Target: $109 → $115
Current: $92.17
Upside: +24.77%
OrthoPediatrics
Aug 4, 2026
Reiterated: Buy
Price Target: $23
Current: $22.08
Upside: +4.17%
SI-BONE
Aug 4, 2026
Rated: Buy
Price Target: $18 → $20
Current: $20.10
Upside: -0.50%
Reiterated: Buy
Price Target: $485
Current: $427.64
Upside: +13.41%
Reiterated: Buy
Price Target: $25
Current: $10.20
Upside: n/a
Reiterated: Hold
Price Target: $10 → $7
Current: $6.42
Upside: n/a
Reiterated: Buy
Price Target: $100
Current: $85.92
Upside: n/a
Reiterated: Buy
Price Target: $301 → $318
Current: $320.96
Upside: n/a
Reiterated: Buy
Price Target: $50
Current: $9.24
Upside: n/a
Reiterated: Hold
Price Target: $10 → $11
Current: $6.14
Upside: n/a
Reiterated: Buy
Price Target: $3
Current: $2.26
Upside: n/a